Related Experiment Videos
[Differential therapy of acute occlusion of leg arteries]
1Abteilung Angiologie, Medizinische Hochschule Hannover.
Medizinische Klinik (Munich, Germany : 1983)
|October 15, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV.
VASA. Zeitschrift fur Gefasskrankheiten·2004
[Therapy of venous thromboembolism with low-molecular-weight heparins].
VASA. Zeitschrift fur Gefasskrankheiten·2000
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Journal of the American College of Cardiology·1998
Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
VASA. Zeitschrift fur Gefasskrankheiten·1998
[75-year old female with progressive idiopathic lung fibrosis].
Medizinische Klinik (Munich, Germany : 1983)·2011
[Mesenterial lymphangiolipoma - a rare finding in an asymptomatic patient].
Medizinische Klinik (Munich, Germany : 1983)·2011
[Resistant hypertension despite nine different antihypertensive drugs?].
Medizinische Klinik (Munich, Germany : 1983)·2011
[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].
Medizinische Klinik (Munich, Germany : 1983)·2011
[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary].
Medizinische Klinik (Munich, Germany : 1983)·2011
[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].
Medizinische Klinik (Munich, Germany : 1983)·2011
Astilbin: a novel therapeutic strategy for bone destruction in rheumatoid arthritis.
Frontiers in immunology·2026
Age does not modify the effects of treatment on pain in patients with low back pain: Secondary analyses of randomized clinical trials.
European journal of pain (London, England)·2026